New York State Common Retirement Fund Spruce Biosciences, Inc. Transaction History

New York State Common Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.28 - $2.23 $7,581 - $13,208	-5,923 Reduced 98.72%	77 $0
Q1 2022 May 05, 2022	SELL	$1.85 - $4.59 $168 - $417	-91 Reduced 1.49%	6,000 $12,000
Q3 2021 Nov 02, 2021	BUY	$6.01 - $11.26 $192 - $360	32 Added 0.53%	6,091 $37,000
Q2 2021 Aug 02, 2021	BUY	$10.12 - $17.46 $597 - $1,030	59 Added 0.98%	6,059 $68,000
Q1 2021 May 11, 2021	BUY	$14.8 - $25.79 $41,440 - $72,212	2,800 Added 87.5%	6,000 $100,000
Q4 2020 Feb 08, 2021	BUY	$15.38 - $32.42 $49,216 - $103,744	3,200 New	3,200 $78,000

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.42M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.